1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Experimental Mammary Neoplasms in 2 studies
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study was conducted to develop novel fasudil derivatives after incorporation of substituted thiazoles as potent anti-breast cancer (BC) agents." | 8.02 | Design and development of novel fasudil derivatives as potent antibreast cancer agent that improves intestinal flora and intestinal barrier function in rats. ( Fu, A; Huang, R; Liang, J; Tang, M; Wang, L; Zhou, J, 2021) |
| "This study was conducted to develop novel fasudil derivatives after incorporation of substituted thiazoles as potent anti-breast cancer (BC) agents." | 4.02 | Design and development of novel fasudil derivatives as potent antibreast cancer agent that improves intestinal flora and intestinal barrier function in rats. ( Fu, A; Huang, R; Liang, J; Tang, M; Wang, L; Zhou, J, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liang, J | 1 |
| Tang, M | 1 |
| Wang, L | 1 |
| Huang, R | 1 |
| Fu, A | 1 |
| Zhou, J | 1 |
| Aguirre Ghiso, JA | 1 |
| Alonso, DF | 1 |
| Farías, EF | 1 |
| Bal de Kier Joffé, E | 1 |
2 other studies available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Design and development of novel fasudil derivatives as potent antibreast cancer agent that improves intestinal flora and intestinal barrier function in rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Antineoplastic Agents; Breast Neoplasms; Col | 2021 |
Overproduction of urokinase-type plasminogen activator is regulated by phospholipase D- and protein kinase C-dependent pathways in murine mammary adenocarcinoma cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 1-Butanol; Adenocarcinoma; Animals; Butanols; Epiderm | 1997 |